Full-Time
Confirmed live in the last 24 hours
Enhances patient engagement using AI solutions
$175k - $200kAnnually
Expert
No H1B Sponsorship
Remote in USA
Applicants must reside full-time in the US and be authorized to work in the US without sponsorship.
You match the following Lirio's candidate preferences
Employers are more likely to interview you if you match these preferences:
Lirio focuses on improving patient engagement and health outcomes in the healthcare sector by utilizing behavioral science and artificial intelligence. The company provides solutions that encourage patients to schedule and attend important health screenings, such as mammograms and colorectal cancer screenings. Their main product, Precision Nudging, applies behavioral science principles to positively influence patient behavior and is integrated into healthcare providers' systems to keep patients engaged in their health. Unlike many competitors, Lirio addresses both external and internal barriers that prevent patients from attending appointments, which enhances healthcare delivery. The company's goal is to improve overall patient outcomes through proactive health management, and it generates revenue through subscription services and partnerships with healthcare organizations.
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$4M
Headquarters
Knoxville, Tennessee
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Company Match
10 paid holidays + holiday week company closure
Unlimited Paid Time Off
Hybrid Work Options
Strategy | Financing Transactions Private Placement / Financing Transactions Cellanome: The company raised $150 million of Series B venture funding from Premji Invest (US) and undisclosed investors on January 29, 2024, putting the company’s pre-money valuation at $375 million. The company is a developer of a unique multi-omics platform designed to measure biology at an unprecedented […]
Like this story? Please share!. .